Although PIVKA-II levels are increased in the serum of patients with HCC, there is no established correlation between PIVKA-II and AFP levels; hence, PIVKA-II could serve as a complementary TM in HCC diagnosis. This evidence concerns the gene AFP and hepatocellular carcinoma.